首页 | 本学科首页   官方微博 | 高级检索  
     

疏血通注射液联合依达拉奉治疗急性脑梗死的临床观察
引用本文:甄君,李静,姚晓黎,刘汉伟,徐晓华. 疏血通注射液联合依达拉奉治疗急性脑梗死的临床观察[J]. 中国实用医药, 2011, 6(19): 25-26
作者姓名:甄君  李静  姚晓黎  刘汉伟  徐晓华
作者单位:1. 中山大学附属第五医院康复医学科,珠海,519000
2. 中山大学附属第五医院神经内科,珠海,519000
3. 中山大学附属第一医院神经内科
摘    要:目的观察疏血通注射液联合依达拉奉治疗急性脑梗死的疗效和安全性。方法 90例急性脑梗死患者随机分为治疗组(46例)与对照组(44例),治疗组予疏血通注射液联合依达拉奉治疗,对照组予疏血通注射液治疗,观察两组患者治疗后美国国立卫生研究院卒中量表(NIHSS)评分的改善情况以及临床疗效。结果治疗组在治疗后的NIHSS评分较对照组明显降低,差异有统计学意义(P<0.05);治疗组的总有效率为87%,常规对照组为65.9%,差异有统计学意义(P<0.05)。结论疏血通注射液联合依达拉奉能够促进急性脑梗死患者的神经功能康复、减少致残率、提高疗效,且无明显不良反应。

关 键 词:脑梗死  疏血通注射液  依达拉奉

Clinical observation on combining Shuxuetong injection with edaravone in treatment of patients with acute cerebral infarction
ZHEN Jun,LI Jing,YAO Xiao-li,et al.. Clinical observation on combining Shuxuetong injection with edaravone in treatment of patients with acute cerebral infarction[J]. China Practical Medical, 2011, 6(19): 25-26
Authors:ZHEN Jun  LI Jing  YAO Xiao-li  et al.
Affiliation:ZHEN Jun,LI Jing,YAO Xiao-li,et al. Department of Rehabilitation Medicine,the Fifth Affiliated Hospital of Sun Yat-Sen University,Zhuhai 519000,China
Abstract:Objective To investigate the clinical effect and safety of combining Shuxuetong injection with Edaravone in treatment of patients with acute cerebral infarction. Methods 90 patients with acute cerebral infarction were randomly divided into treatment group(46 cases)and control group(44 cases),The treatment group received the treatment of combining Shuxuetong injection with Edaravone, while the control group was given Shuxuetong injection.The National Insitute of Health Stroke Scale(NIHSS)scores and the clini...
Keywords:Cerebral infarction  Shuxuetong injection  Edaravone  
本文献已被 CNKI 维普 万方数据 等数据库收录!
设为首页 | 免责声明 | 关于勤云 | 加入收藏

Copyright©北京勤云科技发展有限公司  京ICP备09084417号